These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 18596031)

  • 41. The dual topoisomerase inhibitor A35 preferentially and specially targets topoisomerase 2α by enhancing pre-strand and post-strand cleavage and inhibiting DNA religation.
    Zhao W; Jiang G; Bi C; Li Y; Liu J; Ye C; He H; Li L; Song D; Shao R
    Oncotarget; 2015 Nov; 6(35):37871-94. PubMed ID: 26462155
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human small cell lung cancer NYH cells selected for resistance to the bisdioxopiperazine topoisomerase II catalytic inhibitor ICRF-187 demonstrate a functional R162Q mutation in the Walker A consensus ATP binding domain of the alpha isoform.
    Wessel I; Jensen LH; Jensen PB; Falck J; Rose A; Roerth M; Nitiss JL; Sehested M
    Cancer Res; 1999 Jul; 59(14):3442-50. PubMed ID: 10416608
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DNA-PK inhibition extends the therapeutic effects of Top2 poisoning to non-proliferating cells, increasing activity at a cost.
    Wang T; Kyle AH; Baker JHE; Liu NA; Banáth JP; Minchinton AI
    Sci Rep; 2023 Aug; 13(1):12429. PubMed ID: 37528151
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Carbamate analogues of amsacrine active against non-cycling cells: relative activity against topoisomerases IIalpha and beta.
    Turnbull RM; Meczes EL; Perenna Rogers M; Lock RB; Sullivan DM; Finlay GJ; Baguley BC; Austin CA
    Cancer Chemother Pharmacol; 1999; 44(4):275-82. PubMed ID: 10447574
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Topoisomerase IIbeta mediated DNA double-strand breaks: implications in doxorubicin cardiotoxicity and prevention by dexrazoxane.
    Lyu YL; Kerrigan JE; Lin CP; Azarova AM; Tsai YC; Ban Y; Liu LF
    Cancer Res; 2007 Sep; 67(18):8839-46. PubMed ID: 17875725
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TDP2 protects transcription from abortive topoisomerase activity and is required for normal neural function.
    Gómez-Herreros F; Schuurs-Hoeijmakers JH; McCormack M; Greally MT; Rulten S; Romero-Granados R; Counihan TJ; Chaila E; Conroy J; Ennis S; Delanty N; Cortés-Ledesma F; de Brouwer AP; Cavalleri GL; El-Khamisy SF; de Vries BB; Caldecott KW
    Nat Genet; 2014 May; 46(5):516-21. PubMed ID: 24658003
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The iron chelator Dp44mT causes DNA damage and selective inhibition of topoisomerase IIalpha in breast cancer cells.
    Rao VA; Klein SR; Agama KK; Toyoda E; Adachi N; Pommier Y; Shacter EB
    Cancer Res; 2009 Feb; 69(3):948-57. PubMed ID: 19176392
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intercalating TOP2 Poisons Attenuate Topoisomerase Action at Higher Concentrations.
    Atwal M; Swan RL; Rowe C; Lee KC; Lee DC; Armstrong L; Cowell IG; Austin CA
    Mol Pharmacol; 2019 Oct; 96(4):475-484. PubMed ID: 31399497
    [TBL] [Abstract][Full Text] [Related]  

  • 49. RNF168 and USP10 regulate topoisomerase IIα function via opposing effects on its ubiquitylation.
    Guturi KKN; Bohgaki M; Bohgaki T; Srikumar T; Ng D; Kumareswaran R; El Ghamrasni S; Jeon J; Patel P; Eldin MS; Bristow R; Cheung P; Stewart GS; Raught B; Hakem A; Hakem R
    Nat Commun; 2016 Aug; 7():12638. PubMed ID: 27558965
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MRN, CtIP, and BRCA1 mediate repair of topoisomerase II-DNA adducts.
    Aparicio T; Baer R; Gottesman M; Gautier J
    J Cell Biol; 2016 Feb; 212(4):399-408. PubMed ID: 26880199
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of hsa-miR-9-3p and hsa-miR-9-5p on Topoisomerase II
    Carvajal-Moreno J; Hernandez VA; Wang X; Li J; Yalowich JC; Elton TS
    J Pharmacol Exp Ther; 2023 Feb; 384(2):265-276. PubMed ID: 36410793
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proteasomal inhibition potentiates drugs targeting DNA topoisomerase II.
    Lee KC; Bramley RL; Cowell IG; Jackson GH; Austin CA
    Biochem Pharmacol; 2016 Mar; 103():29-39. PubMed ID: 26794000
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Myeloperoxidase inhibition protects bone marrow mononuclear cells from DNA damage induced by the TOP2 poison anti-cancer drug etoposide.
    Cowell IG; Austin CA
    FEBS Open Bio; 2024 Jun; 14(6):1001-1010. PubMed ID: 38531625
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular cloning and characterization of the human topoisomerase IIalpha and IIbeta genes: evidence for isoform evolution through gene duplication.
    Sng JH; Heaton VJ; Bell M; Maini P; Austin CA; Fisher LM
    Biochim Biophys Acta; 1999 Mar; 1444(3):395-406. PubMed ID: 10095062
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dual targeting of microtubule and topoisomerase II by α-carboline derivative YCH337 for tumor proliferation and growth inhibition.
    Yi JM; Zhang XF; Huan XJ; Song SS; Wang W; Tian QT; Sun YM; Chen Y; Ding J; Wang YQ; Yang CH; Miao ZH
    Oncotarget; 2015 Apr; 6(11):8960-73. PubMed ID: 25840421
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ataxia telangiectasia mutated-dependent regulation of topoisomerase II alpha expression and sensitivity to topoisomerase II inhibitor.
    Tamaichi H; Sato M; Porter AC; Shimizu T; Mizutani S; Takagi M
    Cancer Sci; 2013 Feb; 104(2):178-84. PubMed ID: 23163762
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CRISPR/Cas9 Genome Editing of the Human Topoisomerase II
    Hernandez VA; Carvajal-Moreno J; Papa JL; Shkolnikov N; Li J; Ozer HG; Yalowich JC; Elton TS
    Mol Pharmacol; 2021 Mar; 99(3):226-241. PubMed ID: 33446509
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The catalytic topoisomerase II inhibitor dexrazoxane induces DNA breaks, ATF3 and the DNA damage response in cancer cells.
    Deng S; Yan T; Nikolova T; Fuhrmann D; Nemecek A; Gödtel-Armbrust U; Kaina B; Wojnowski L
    Br J Pharmacol; 2015 May; 172(9):2246-57. PubMed ID: 25521189
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of the effect of three different topoisomerase II inhibitors combined with cisplatin in human glioblastoma cells sensitized with double strand break repair inhibitors.
    Macieja A; Kopa P; Galita G; Pastwa E; Majsterek I; Poplawski T
    Mol Biol Rep; 2019 Aug; 46(4):3625-3636. PubMed ID: 31020489
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Studies on Non-synonymous Polymorphisms Altering Human DNA Topoisomerase II-Alpha Interaction with Amsacrine and Mitoxantrone: An
    Farsani FM; Ganjalikhany MR; Vallian S
    Curr Cancer Drug Targets; 2017; 17(7):657-668. PubMed ID: 27834128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.